DEFA14A ·Filed Apr 23, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor the outcome of the shareholder vote, but expect no immediate market impact as the proposals are standard and uncontested.
Final — all horizons settled through T+60d
RAPP ▲ +10.59% at T+60d
NEUTRAL call ✓ call won +10.59% · α vs SPY +5.57% · entry $36.36 → $40.21
T+1d
+0.55%
call +0.55% · α -0.23%
$36.56
settled 6mo ago
T+5d
-9.24%
call -9.24% · α -10.72%
$33.00
settled 6mo ago
T+20d
-1.76%
call -1.76% · α -6.39%
$35.72
settled 5mo ago
T+60d
+10.59%
call +10.59% · α +5.57%
$40.21
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Rapport Therapeutics is holding its 2026 Annual Meeting virtually on June 10, 2026, where shareholders will vote on the election of three Class II directors and the ratification of its independent auditor.
Key Financial Metrics
Vote
director election
Meeting
2026-06-10
Key Facts
- The 2026 Annual Meeting will be held virtually on June 10, 2026, at 1:00 PM ET.
- Shareholders will vote to elect James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors.
- Shareholders will vote to ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026.
- The filing is a definitive proxy statement (DEFA14A) for the annual meeting.
Financial Impact
No direct financial impact from this filing; it is a routine corporate governance matter.
board_compositionauditor_selection
Risk Factors
- Insider selling activity (8 sells totaling $19.2M in the past 30 days) could indicate reduced confidence, but this is not directly related to the proxy vote.
- The routine nature of the vote means no significant governance changes are expected.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-171836 |
| Document: 0001193125-26-171836-index-headers.html | 0001193125-26-171836 |
| Document: 0001193125-26-171836-index.html | 0001193125-26-171836 |
| Document: 0001193125-26-171836.txt | 0001193125-26-171836 |
22 reports for RAPP
67% Hit rate @ T+5 Went positive at some point 6 of 8 best @ T+60▲ +24.87%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | Insider Cluster | $26.00 | awaiting T+5 | — | $25.93 (−0.27%) |
Oct 22, 2026 4d ago | Insider Cluster | $27.33 | awaiting T+5 | — | $25.93 (−5.12%) |
Oct 21, 2026 4d ago | Insider Buy | $26.53 | awaiting T+5 | — | $25.93 (−2.26%) |
Oct 20, 2026 6d ago | 8-K | $29.37 | awaiting T+5 | — | $25.93 (−11.71%) |
Oct 6, 2026 19d ago | 144 | $30.86 $28.33 | ▲ +8.20% | ▲ +7.22% | $25.93 (+15.98%) |
Oct 1, 2026 24d ago | Insider Cluster | $32.17 $30.65 | ▼ −4.72% | ▼ −5.89% | $25.93 (−19.40%) |
Aug 26, 2026 8w ago | Insider Cluster | $50.83 $47.65 | ▼ −6.26% | ▼ −6.52% | $25.93 (−48.99%) |
Aug 5, 2026 11w ago | 8-K | $42.44 $47.73 | ▲ +12.46% | ▲ +12.11% | $25.93 (−38.90%) |
Jul 1, 2026 16w ago | Insider Cluster | $38.97 $41.75 | ▲ +7.13% | ▲ +5.77% | $25.93 (−33.46%) |
Jun 30, 2026 16w ago | 144 | $39.39 $39.72 | ▲ +0.84% | ▲ +0.58% | $25.93 (−34.17%) |
Showing 10 of 22
US Market Status
Market Closed — Opens in 2h 41m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers